Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8496 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.832 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.8209 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.8175 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8175 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8168 |
Intermediate Similarity |
NPD3705 |
Approved |
0.8106 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.8074 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8045 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.8045 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.8015 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7883 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7862 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7815 |
Intermediate Similarity |
NPD37 |
Approved |
0.7778 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7778 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD4965 |
Approved |
0.777 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.777 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7761 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7737 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7724 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7698 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7687 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7677 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7639 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7622 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7554 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7518 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7518 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7518 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7518 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7518 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD5494 |
Approved |
0.75 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7468 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7468 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7463 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7453 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7413 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7413 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7413 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7394 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7391 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7389 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7388 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7375 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7315 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7279 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7261 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7254 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD7157 |
Approved |
0.723 |
Intermediate Similarity |
NPD5763 |
Approved |
0.723 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7215 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7214 |
Intermediate Similarity |
NPD8651 |
Approved |
0.72 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7197 |
Intermediate Similarity |
NPD228 |
Approved |
0.7197 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7195 |
Intermediate Similarity |
NPD8156 |
Discontinued |
0.7179 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7179 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7172 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7172 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7162 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7162 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7162 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7161 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7152 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6896 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD8099 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD8251 |
Approved |
0.7134 |
Intermediate Similarity |
NPD8252 |
Approved |
0.7133 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7123 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7123 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7122 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7117 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7117 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7115 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7114 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7099 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7099 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7097 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7095 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7092 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7089 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7089 |
Intermediate Similarity |
NPD4585 |
Approved |
0.7089 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7078 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7048 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7045 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7045 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7045 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7044 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7029 |
Intermediate Similarity |
NPD3445 |
Approved |
0.7029 |
Intermediate Similarity |
NPD3443 |
Approved |
0.7029 |
Intermediate Similarity |
NPD3444 |
Approved |
0.7021 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.702 |
Intermediate Similarity |
NPD4237 |
Approved |
0.702 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD1281 |
Approved |
0.6988 |
Remote Similarity |
NPD7054 |
Approved |
0.6985 |
Remote Similarity |
NPD709 |
Approved |
0.6985 |
Remote Similarity |
NPD6671 |
Approved |
0.698 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6978 |
Remote Similarity |
NPD4626 |
Approved |
0.6974 |
Remote Similarity |
NPD6331 |
Phase 2 |
0.6974 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6972 |
Remote Similarity |
NPD6696 |
Suspended |
0.697 |
Remote Similarity |
NPD3489 |
Phase 3 |
0.6954 |
Remote Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD5242 |
Approved |
0.6948 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6948 |
Remote Similarity |
NPD1511 |
Approved |
0.6946 |
Remote Similarity |
NPD7472 |
Approved |
0.6937 |
Remote Similarity |
NPD2563 |
Approved |
0.6937 |
Remote Similarity |
NPD2560 |
Approved |
0.6933 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6933 |
Remote Similarity |
NPD1247 |
Approved |
0.6928 |
Remote Similarity |
NPD3818 |
Discontinued |
0.6928 |
Remote Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD2219 |
Phase 1 |
0.6923 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6918 |
Remote Similarity |
NPD5718 |
Phase 2 |
0.6918 |
Remote Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.6917 |
Remote Similarity |
NPD5451 |
Approved |
0.6914 |
Remote Similarity |
NPD919 |
Approved |
0.6913 |
Remote Similarity |
NPD4536 |
Approved |
0.6913 |
Remote Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.6913 |
Remote Similarity |
NPD4538 |
Approved |
0.6908 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6908 |
Remote Similarity |
NPD3060 |
Approved |
0.6906 |
Remote Similarity |
NPD1357 |
Approved |
0.6906 |
Remote Similarity |
NPD5585 |
Approved |
0.6903 |
Remote Similarity |
NPD4584 |
Approved |
0.6903 |
Remote Similarity |
NPD7447 |
Phase 1 |
0.6901 |
Remote Similarity |
NPD1669 |
Approved |
0.6899 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6894 |
Remote Similarity |
NPD6788 |
Approved |
0.6894 |
Remote Similarity |
NPD290 |
Approved |
0.6892 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6892 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.689 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6889 |
Remote Similarity |
NPD5535 |
Approved |
0.6887 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6879 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6875 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD2154 |
Approved |
0.6867 |
Remote Similarity |
NPD2156 |
Approved |
0.6867 |
Remote Similarity |
NPD2155 |
Approved |
0.6863 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6863 |
Remote Similarity |
NPD3750 |
Approved |
0.6861 |
Remote Similarity |
NPD6387 |
Discontinued |
0.6859 |
Remote Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.6859 |
Remote Similarity |
NPD52 |
Approved |
0.6859 |
Remote Similarity |
NPD7526 |
Approved |
0.6859 |
Remote Similarity |
NPD1512 |
Approved |
0.6857 |
Remote Similarity |
NPD17 |
Approved |
0.6855 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6853 |
Remote Similarity |
NPD1283 |
Approved |
0.6849 |
Remote Similarity |
NPD7095 |
Approved |
0.6849 |
Remote Similarity |
NPD2669 |
Clinical (unspecified phase) |
0.6846 |
Remote Similarity |
NPD4097 |
Suspended |
0.6846 |
Remote Similarity |
NPD6353 |
Approved |
0.6842 |
Remote Similarity |
NPD2808 |
Discontinued |
0.6842 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD1372 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD8054 |
Approved |
0.6842 |
Remote Similarity |
NPD8053 |
Approved |
0.6839
|
Remote Similarity |
NPD7040 |
Clinical (unspecified phase) |